School of Food Science and Technology, Jiangnan University, Wuxi, JiangSu 214122, PR China.
Immunol Invest. 2011;40(1):14-28. doi: 10.3109/08820139.2010.507687. Epub 2010 Sep 1.
A new competitive bead immunoassay (CBIA) based on Luminex technology for detecting clenbuterol in urine was reported. The carboxylated fluorescent beads were directly coated with clenbuterol derivatives without carrier protein spacer. Clenbuterol antibody was biotinylated, which was used for clenbuterol detection in combination with the functionalized bead and streptavidin-phycoerythrin (SAPE). The effects of spacer on the CBIA method were investigated. The results indicated that the presence of small molecular spacer between bead and hapten improved the assay sensitivity and the hydrophilic spacer (glycine) was better than the hydrophobic spacer (m-aminobenzoic acid) for this CBIA method. The study affirms the importance of the judicious choice of hapten derivatives in the CBIA method for detecting small molecule drug based on Luminex technology. The method could be used for clenbuterol detection in livestock urine and possible for the simultaneous detection of multiple veterinary drugs.
一种基于Luminex 技术的新型竞争 bead 免疫分析(CBIA)被报道用于检测尿液中的克伦特罗。羧基化荧光珠未经载体蛋白间隔臂直接包被克伦特罗衍生物。克伦特罗抗体被生物素化,用于与功能化珠和链霉亲和素-藻红蛋白(SAPE)结合检测克伦特罗。研究了间隔臂对 CBIA 方法的影响。结果表明,珠和半抗原之间小分子间隔臂的存在提高了检测灵敏度,亲水间隔臂(甘氨酸)比疏水间隔臂(间氨基苯甲酸)更适合该 CBIA 方法。该研究证实了在基于 Luminex 技术的小分子药物 CBIA 方法中,明智选择半抗原衍生物的重要性。该方法可用于检测畜尿中的克伦特罗,也可能用于同时检测多种兽药。